The FDA issued its second Class I recall in as many weeks to Philips’ sleep and respiratory care division, offering up its most serious classification for a safety issue that could inadvertently lower ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果